ArticleJournal of molecular medicine (Berlin, Germany)2018

Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation.

Akiko Eguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.